GE Vernova Inc.

# Signal Note: Eventide Initiates GE Vernova Position **Not applicable to biotech analysis.** GE Vernova (GEV) is a pure-play energy infrastructure company spun from GE, focused on grid-scale energy storage and renewable power systems—outside traditional pharma/biotech development pipelines. Eventide's $122.4M entry likely reflects their ESG mandate toward clean energy rather than clinical/commercial biotech catalysts; this position does not signal near-term drug approval, efficacy data, or regulatory milestones typical of biotech investment thesis.